| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1471-4159.1986.TB00649.X |
| P698 | PubMed publication ID | 3081686 |
| P2093 | author name string | S M Paul | |
| P Berger | |||
| A Janowsky | |||
| F Vocci | |||
| P Skolnick | |||
| R Labarca | |||
| P2860 | cites work | [3H]GBR-12935: a specific high affinity ligand for labeling the dopamine transport complex | Q34197752 |
| Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity | Q40088615 | ||
| Quantitative autoradiography of 3H-nomifensine binding sites in rat brain | Q41495548 | ||
| The effects of surgical and chemical lesions on striatal [3H]threo-(+/-)-methylphenidate binding: correlation with [3H]dopamine uptake | Q44428661 | ||
| Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: Specific inhibitors of dopamine uptake | Q48633845 | ||
| The uptake of (3H)dopamine by homogenates of rat corpus striatum: effects of cations | Q48638012 | ||
| Saturable (3H)cocaine binding in central nervous system of mouse | Q51874092 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1272-1276 | |
| P577 | publication date | 1986-04-01 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Characterization of sodium-dependent [3H]GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complex | |
| P478 | volume | 46 |
| Q34761427 | 3H1-2-(2-thienyl)cyclohexylpiperidine labels two high-affinity binding sites in human cortex: Further evidence for phencyclidine binding sites associated with the biogenic amine reuptake complex |
| Q48261159 | Allosteric regulation by sodium of the binding of [3H]cocaine and [3H]GBR 12935 to rat and bovine striata |
| Q28537732 | Antidepressant-like activity of YL-0919: a novel combined selective serotonin reuptake inhibitor and 5-HT1A receptor agonist |
| Q48609820 | Attenuation of pulsatile changes in the density of striatal [3H]GBR-12935 binding sites during chronic ethanol consumption |
| Q67513939 | Autoradiographic localization of dopamine uptake sites in the rat brain with 3H-GBR 12935 |
| Q51557207 | Binding domains for blockers and substrates on the cloned human dopamine transporter studied by protection against N-ethylmaleimide-induced reduction of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)[3H]tropane ([3H]WIN 35,428) binding. |
| Q48317229 | Characterization of both dopamine uptake systems in rat striatal slices by specific pharmacological tools |
| Q41042387 | Characterization of the human dopamine transporter heterologously expressed in BHK-21 cells |
| Q36604318 | Cocaine as a naturally occurring insecticide |
| Q43458533 | Comparison of characteristics of dopamine uptake and mazindol binding in mouse striatum |
| Q50870752 | Computational modeling of extracellular dopamine kinetics suggests low probability of neurotransmitter release. |
| Q52208910 | Developmental and age-related alterations in rat brain presynaptic dopaminergic mechanisms |
| Q44072410 | Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H] mazindol autoradiography |
| Q48555588 | Dopamine uptake sites, labelled with [3H]GBR12935, in brain samples from depressed suicides and controls |
| Q48291787 | Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites |
| Q34252846 | Effects of amphetamine on subcellular distribution of dopamine and DOPAC. |
| Q42454867 | Effects of prenatal methylazoxymethanol treatment on striatal dopaminergic systems in rat brain |
| Q34297799 | Effects of various dopamine uptake inhibitors on striatal extracellular dopamine levels and behaviours in rats |
| Q33904891 | Enantioselective behavioral effects of sibutramine metabolites |
| Q40579255 | Identification of dopamine transporter in bovine pineal gland using [3H]GBR 12935. |
| Q44514897 | In vivo binding of [18F]GBR 13119 to the brain dopamine uptake system |
| Q37462990 | Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervation |
| Q74254242 | Increased dopamine uptake in striatal synaptosomes after treatment of rats with amantadine |
| Q35581528 | Interactions of cations and anions with the binding of uptake blockers to the dopamine transporter |
| Q72232546 | Invariance of the density of dopamine uptake sites and dopamine metabolism in the rat brain after a chronic treatment with the dopamine uptake inhibitor GBR 12783 |
| Q67749896 | Kinetic Analysis of the Chloride Dependence of the Neuronal Uptake of Dopamine and Effect of Anions on the Ability of Substrates to Compete with the Binding of the Dopamine Uptake Inhibitor GBR 12783 |
| Q72111882 | Long-term effects of amygdaloid kindling on striatal dopaminergic terminals |
| Q41084722 | MPTP lesions of the nigrostriatal dopaminergic projection decrease [3H]1-[1-(2-thienyl)cyclohexyl]-piperidine binding to PCP site 2: Further evidence that PCP site 2 is associated with the biogenic amine reuptake complex |
| Q48626286 | MPTP toxicity in rat striatal slices: dopamine uptake alteration does not appear to be related to lipid peroxidation |
| Q51482161 | Neurochemical binding profiles of novel indole and benzofuran MDMA analogues. |
| Q73024860 | Neuropharmacological characterization of local ibogaine effects on dopamine release |
| Q52537567 | Origin of 4-hydroxynonenal incubation-induced inhibition of dopamine transporter and Na+/K+ adenosine triphosphate in rat striatal synaptosomes. |
| Q37164698 | PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter |
| Q43819039 | Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)nortropane (PE2I) binding to the rat neuronal dopamine transporter expressed in COS cells |
| Q83084099 | Poster communications |
| Q52052253 | Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics |
| Q48512434 | Radiolabeling of dopamine uptake sites in mouse striatum: comparison of binding sites for cocaine, mazindol, and GBR 12935 |
| Q48663473 | Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum |
| Q48372130 | Specificity and ion dependence of binding of GBR analogs |
| Q51700514 | Stereoselective behavioral effects of Lu 19-005 in monkeys: relation to binding at cocaine recognition sites |
| Q44589849 | Strain differences in the distribution of dopamine transporter sites in rat brain |
| Q52272899 | Studies of the biogenic amine transporters. 1. Dopamine reuptake blockers inhibit [3H]mazindol binding to the dopamine transporter by a competitive mechanism: preliminary evidence for different binding domains. |
| Q71798622 | Subcellular distribution of receptor sites in human brain: Differentiation between heavy and light structures of high and low density |
| Q28290932 | The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease |
| Q24633511 | The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization properties |
| Q51744257 | Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs. |
| Q51149393 | Uterine adenocarcinoma in the rat induced by afidopyropen. An analysis of the lesion's induction, progression and its relevance to humans. |
| Q61714004 | [3H] GBR 12935 binding to the dopamine uptake site in post-mortem brain tissue in schizophrenia |
Search more.